Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03183388 · ClinicalTrials.gov registry record · NA
Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT03183388 is a NA study that has completed, run by Yale University. The registered enrollment target is 76 participants.
The verdict
NCT03183388, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
New treatments to help to reduce the emotional dysregulation of mood disorders are critically needed. This is a study of an emotional dysregulation psychotherapy treatment in which participants will learn skills to help to down-regulate maladaptive emotional responses and learn beneficial, healthy habits. Investigators will perform symptom and behavioral assessments and scanning prior to the treatment and will then repeat scanning, symptom and behavioral assessments at the midpoint, and after the psychotherapy is completed. This collected information will assess whether the treatment can improve functioning of emotion regulation brain circuitry.
Interventions
- BEHAVIORAL BE-SMART
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03183388
The ClinicalTrials.gov registry entry for NCT03183388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BE-SMART is the first listed.
NCT03183388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03183388 about?
NCT03183388 is a clinical study titled "Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)". New treatments to help to reduce the emotional dysregulation of mood disorders are critically needed. This is a study of an emotional dysregulation psychotherapy treatment in which participants will learn skills to help to down-regulate maladaptive emotional responses and learn beneficial, healthy h...
What is the current status of trial NCT03183388?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2017-10-17. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03183388?
The interventions under investigation include: BE-SMART (BEHAVIORAL).
Who is sponsoring clinical trial NCT03183388?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.